GlassScriptPhysician profile
Jacob Abraham
NPI 1548223381
$330,854.73
in general payments reported to CMS, 2019-2025
22 companies · $62K in 2025
The $62K reported for 2025 was more than what 95% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $17K · 2021: $38K · 2022: $45K · 2023: $73K · 2024: $78K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $85K · Consulting Fee: $84K · Travel and Lodging: $26K · Food and Beverage: $17K · Education: $61.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $85,450.00 |
| Consulting Fee | $83,857.50 |
| Travel and Lodging | $26,290.42 |
| Food and Beverage | $16,516.13 |
| Education | $61.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $194,912.44 | 2019-2025 | Impella |
| Abbott Laboratories | $96,872.11 | 2019-2025 | Cardiomems, Freestyle Libre Pro, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $18,116.14 | 2022-2025 | Barostim Neo System |
| Endotronix, INC. | $10,257.05 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Ancora Heart, INC. | $6,460.16 | 2021-2025 | Accucinch |
| Impedimed, INC. | $1,000.00 | 2020 | |
| Biosense Webster, INC. | $800.00 | 2023 | Carto 3 |
| Merit Medical Systems INC | $600.00 | 2024 | |
| Medtronic Vascular, INC. | $332.18 | 2019-2020 | |
| Edwards Lifesciences Corporation | $328.52 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.82 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $203.17 | 2022-2023 | Atacand |
| Impulse Dynamics (USA) INC. | $185.36 | 2022-2024 | Optimizer |
| Zoll Respicardia, INC. | $122.50 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.32 | 2023-2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Regent | $87.11 | 2025 | Injectafer |
| Medtronic, INC. | $63.06 | 2021-2023 | Hvad Pump Implant Kit |
| Cardiac Dimensions, INC. | $61.49 | 2024-2025 | |
| Nuwellis, INC. | $32.58 | 2020 | |
| Penumbra, INC. | $22.50 | 2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $19.80 | 2019 | |
| Amarin Pharma, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.